Medicare Enrolled
Dr. Kong Truong, M.D.
Neurology · Fountain Valley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Truong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Truong?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Truong
Dr. Kong Truong is a neurology specialist in Fountain Valley, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Truong performed 542 Medicare services across 240 unique beneficiaries.
Between the years covered by Open Payments, Dr. Truong received a total of $26,817 from 78 pharmaceutical and/or device companies across 1541 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Truong is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 46% volume in CA
$26,817 industry payments
Medicare Practice Summary
Medicare Utilization ↗542
Medicare services
Top 46% in CA for neurology
240
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~36 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
329 | $101 | $165 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
136 | $101 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $140 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $147 | $350 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
18 | $79 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$26,817
Total received (2018-2024)
Avg $3,831/year across 7 years
Top 13% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
1,541
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,508 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$309 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,449
2023
$4,340
2022
$4,288
2021
$4,285
2020
$3,125
2019
$2,972
2018
$2,358
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$871
MDD US Operations, LLC
$857
UCB, Inc.
$564
ACADIA Pharmaceuticals Inc
$347
Ipsen Biopharmaceuticals, Inc
$297
Neurocrine Biosciences, Inc.
$269
SK Life Science, Inc.
$261
Amneal Pharmaceuticals LLC
$258
Novartis Pharmaceuticals Corporation
$241
PFIZER INC.
$236
Eisai Inc.
$175
Merz Pharmaceuticals, LLC
$160
Biogen, Inc.
$141
Lilly USA, LLC
$100
Kyowa Kirin, Inc.
$89
CATALYST PHARMACEUTICALS, INC.
$82
Teva Pharmaceuticals USA, Inc.
$73
GE HEALTHCARE
$69
Alexion Pharmaceuticals, Inc.
$52
Celgene Corporation
$44
Azurity Pharmaceuticals, Inc.
$36
REVANCE THERAPEUTICS, INC.
$34
CSL Behring
$34
Takeda Pharmaceuticals U.S.A., Inc.
$33
Averitas Pharma Inc.
$30
TG Therapeutics, Inc.
$24
Neurelis, Inc.
$21
BANNER LIFE SCIENCES, LLC
$19
Boston Scientific Corporation
$17
JAZZ PHARMACEUTICALS INC.
$16
Top 3 companies account for 42.1% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$1,544
Biogen, Inc.
$1,467
ACADIA Pharmaceuticals Inc
$1,437
UCB, Inc.
$1,417
ABBVIE INC.
$1,381
Novartis Pharmaceuticals Corporation
$1,370
MDD US Operations, LLC
$1,277
Teva Pharmaceuticals USA, Inc.
$1,249
AbbVie Inc.
$1,051
Sunovion Pharmaceuticals Inc.
$972
SK Life Science, Inc.
$964
Amneal Pharmaceuticals LLC
$819
Merz Pharmaceuticals, LLC
$819
Ipsen Biopharmaceuticals, Inc
$806
Kyowa Kirin, Inc.
$761
Eisai Inc.
$721
CSL Behring
$563
Boston Scientific Corporation
$549
PFIZER INC.
$429
Adamas Pharmaceuticals, Inc.
$401
Amgen Inc.
$396
Acorda Therapeutics, Inc
$374
Avion Pharmaceuticals
$352
Lilly USA, LLC
$295
Biohaven Pharmaceutical Holding Company Ltd.
$283
Alexion Pharmaceuticals, Inc.
$275
Avanir Pharmaceuticals, Inc.
$263
Lundbeck LLC
$258
GENZYME CORPORATION
$252
EISAI INC.
$237
Allergan, Inc.
$226
Takeda Pharmaceuticals U.S.A., Inc.
$209
Merz North America, Inc.
$196
GE HEALTHCARE
$174
MERZ NORTH AMERICA, INC.
$170
EMD Serono, Inc.
$164
Biohaven Pharmaceuticals, Inc.
$156
Celgene Corporation
$145
Allergan Inc.
$136
GE HealthCare
$127
Vertical Pharmaceuticals, LLC
$124
Grifols USA, LLC
$115
AstraZeneca Pharmaceuticals LP
$114
Greenwich Biosciences, Inc.
$114
CATALYST PHARMACEUTICALS, INC.
$113
Abbott Laboratories
$111
Azurity Pharmaceuticals, Inc.
$105
Janssen Pharmaceuticals, Inc
$98
GE Healthcare
$86
MITSUBISHI TANABE PHARMA AMERICA, INC.
$83
Impax Laboratories, Inc.
$80
Banner Life Sciences, LLC
$75
ARGENX US, INC.
$72
Sumitomo Pharma America, Inc.
$68
Arbor Pharmaceuticals, Inc.
$65
Neurelis, Inc.
$61
BANNER LIFE SCIENCES, LLC
$59
Medtronic USA, Inc.
$52
Akcea Therapeutics, Inc.
$51
Catalyst Pharmaceuticals, Inc.
$51
US WorldMeds, LLC
$49
Mallinckrodt Enterprises LLC
$43
REVANCE THERAPEUTICS, INC.
$34
Synergy Pharmaceuticals Inc
$32
Ironwood Pharmaceuticals, Inc
$32
Averitas Pharma Inc.
$30
PORTOLA PHARMACEUTICALS, INC.
$28
E.R. Squibb & Sons, L.L.C.
$28
Supernus Pharmaceuticals, Inc.
$25
TG Therapeutics, Inc.
$24
Xeris Pharmaceuticals, Inc.
$19
Mylan Pharmaceuticals Inc.
$17
JAZZ PHARMACEUTICALS INC.
$16
Upsher-Smith Laboratories LLC
$16
Ultragenyx Pharmaceutical Inc.
$15
ASSERTIO THERAPEUTICS, Inc.
$14
LivaNova USA, Inc.
$12
Travere Therapeutics, Inc.
$1
Top 3 companies account for 16.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APOKYN · APTIOM · ARZERRA · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Amitiza · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · COMIRNATY · COPAXONE · CREXONT · Cambia · Cholbam · DAXI · DAXXIFY · DAYBUE · DUOPA · DYSPORT · Dhivy · Dysport · EMGALITY · Epidiolex · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · General - DBS · Glatiramer Acetate · Gocovri · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LINZESS · LONHALA MAGNAIR · LORZONE · Leqembi · Linzess · MAYZENT · MOTEGRITY · MYOBLOC · Mavenclad · Motegrity · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · OSMOLEX ER · Ongentys · Ponvory · QULIPTA · QUTENZA · RADICAVA · RELEXXII · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · Soliris · TECFIDERA · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TYSABRI · Trintellix · Trulance · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · XEOMIN · XYWAV · Xadago · Xeomin · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
266
Per 100K population
8.4
County median income
$113,702
Nearest hospital
UCI HEALTH - FOUNTAIN VALLEY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Truong is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 13% of CA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Truong experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Truong performed 329 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Truong receive payments from pharmaceutical companies?
Yes. Dr. Truong received a total of $26,817 from 78 companies across 1,541 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Truong's costs compare to other neurologists in Fountain Valley?
Dr. Truong's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Truong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Fountain Valley
Browse neurologists in Fountain Valley ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology